Interleukin 37: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 27: | Line 27: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 15:07, 17 March 2025
Interleukin 37 (IL-37) is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system. IL-37 is known for its anti-inflammatory properties and is involved in various biological processes.
Structure[edit]
IL-37 is a protein that is encoded by the IL37 gene in humans. It is a member of the IL-1 family and shares similar gene structure. The IL37 gene is located on chromosome 2 and consists of 6 exons. The protein product is a precursor protein that is processed into its active form by caspase-1.
Function[edit]
IL-37 is primarily known for its anti-inflammatory role. It is produced by immune cells in response to inflammatory stimuli and acts to suppress the immune response. This is achieved by inhibiting the production of pro-inflammatory cytokines and enhancing the production of anti-inflammatory cytokines. IL-37 can also induce the production of regulatory T cells, further contributing to its anti-inflammatory effects.
Clinical significance[edit]
Due to its anti-inflammatory properties, IL-37 has been implicated in a number of diseases. High levels of IL-37 have been found in patients with autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. It has also been associated with cancer, with studies showing that IL-37 can inhibit tumor growth and metastasis.
Research[edit]
Research into IL-37 is ongoing, with studies aiming to further understand its role in the immune system and its potential as a therapeutic target. Current research is focused on understanding the mechanisms by which IL-37 exerts its anti-inflammatory effects and how these can be harnessed for the treatment of inflammatory and autoimmune diseases.
See also[edit]
